Harm Reduction Coverage and Hepatitis C Incidence: Findings From a Cohort of People Who Inject Drugs
Nanor Minoyan, Andreea Adelina Artenie, Geng Zang, Didier Jutras‐Aswad, Marie-Ève Turcotte, Julie Bruneau
Topics & Concepts
MedicineSyringeHarm reductionBuprenorphineMethadoneHazard ratioHepatitis CIncidence (geometry)AgonistInternal medicineCohortProportional hazards modelOpioidEmergency medicinePharmacologyConfidence intervalVirologyPsychiatryHuman immunodeficiency virus (HIV)PhysicsOpticsReceptorHIV, Drug Use, Sexual RiskHepatitis C virus researchOpioid Use Disorder Treatment